arrow
G

Giuseppe Viscardi

University of Salerno
H指数:25
被引数:2,967

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysis

新辅助化疗免疫疗法治疗可切除非小细胞肺癌的手术结果:一项系统评价和荟萃分析

2026-04-160
PRE
APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer

APOLLO11: 用于肺癌临床和转化研究的生物数据驱动模型

2026-01-290
OAAI
Performance of Control Arms in Trials Leading to FDA Cancer Approvals

FDA癌症审批试验中控制臂的性能

2026-01-010
PRE
Adjuvant atezolizumab in surgically resected NSCLC patients with PD-L1 expression ≥50%: real-world data from the italian ATLAS registry
2025-12-240
OA
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysis

免疫疗法在晚期非小细胞肺癌III期试验中,ORR与PFS与OS结局的相关性:系统评价与Meta分析

2025-12-160
OAAI
Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trials

在可切除非小细胞肺癌患者中使用佐剂、新辅助和围手术期免疫治疗为基础的治疗方案的损耗情况。前瞻性试验的荟萃分析

2025-09-220
PREAI
Impact of platinum-based chemotherapy and CTLA-4 inhibition on acquired resistance to first-line anti-PD-1/PD-L1 agents in non-small cell lung cancer: a systematic review and reconstructed individual patient data analysis

铂类化疗和CTLA-4抑制对非小细胞肺癌中一线抗PD-1/PD-L1药物获得性耐药的影响:一项系统综述和重构的个体患者数据分析

2025-09-020
PREAI
Predictive role of functional respiratory tests in LUng toxicity in stage III NSCLC treated with chemo-, raDIO- and immuno-therapy: PRELUDIO TRIAL

功能性呼吸测试在III期NSCLC患者接受化疗、放疗和免疫治疗时预测肺毒性的作用:PRELUDIO试验

2025-06-060
PRE
Unleashing precision: A review of targeted approaches in pleural mesothelioma (vol 203C, 104481, 2024)
2024-12-010
PRE
Unleashing precision: A review of targeted approaches in pleural mesothelioma
2024-11-012
OAAI
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)

奥希替尼在具有罕见表皮生长因子受体突变的非小细胞肺癌中的活性: 回顾性观察性多中心研究 (ARTICUNO)

2024-06-011
OAAI
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research
2024-03-011
OAAI
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy
2024-01-183
OAAI
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review

免疫肿瘤学中预测生物标志物发现的人工智能: 系统综述

2024-01-0138
OAAI
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies
2023-12-0110
PRE
Consolidative thoracic radiotherapy of extensive-stage small cell lung cancer in the era of chemoimmunotherapy: A retrospective analysis concerning patients from southern Italy
2023-10-010
PRE